secretagogue

(redirected from secretagogues)
Also found in: Dictionary.

secretagogue

 [se-krēt´ah-gog]
1. causing a flow of secretion.
2. an agent that so acts.

se·cre·ta·gogue

(se-krē'tă-gog), Avoid the misspelling secretogogue.
An agent that promotes secretion; for example, acetylcholine, gastrin, secretin.
[secreta + G. agōgos, drawing forth]

secretagogue

/se·cret·a·gogue/ (se-krēt´ah-gog) stimulating secretion, or an agent that so acts.

secretagogue

(sĭ-krē′tə-gôg′, -gŏg′)
n.
A hormone or another agent that causes or stimulates secretion.

secretagogue

[sikrē′təgog′]
any agent that induces exocrine, endocrine, or paracrine secretion.

se·cre·ta·gogue

, secretogogue (sĕ-krētă-gog, -tŏ-gog)
An agent that promotes secretion (e.g., acetylcholine, gastrin, secretin).
[secreta + G. agōgos, drawing forth]

se·cre·ta·gogue

, secretogogue (sĕ-krētă-gog, -tŏ-gog)
Agent that promotes secretion.
[secreta + G. agōgos, drawing forth]

secretagogue

1. causing a flow of secretion.
2. an agent that stimulates secretion.
References in periodicals archive ?
Insulin secretagogues agent can be used alone in patients with type 2 diabetes where non-drug treatment fail to work.
Each of the secretagogues use a different pathway of mast cell activation and these pathways may be differentially sensitive to the action of hydroxytyrosol or oleuropein.
Insulin secretagogues are anti-diabetic drugs that help manage blood sugar by increasing the production of insulin in the body.
On the other hand, insulin acts as a potent secretagogue of leptin from adipocytes (Barr et al.
Nutritional restriction during gestation is associated with decreased body size at birth, decreased insulin responses to various secretagogues, increased whole-body insulin sensitivity and receptor expression, and selective resistance to inhibition of lipolysis by insulin.
Further, Holt examines the mechanisms offered as the basis for GH therapies, so-called secretagogues that may or may or accomplish the work of GH injections.
It has only recently been appreciated that reactive oxygen intermediates have broad potential to act as secretagogues, enzyme activators (17-20) and regulators of transcription along with their more familiar roles as enzyme inactivators, antiseptics, cytotoxins, and mutagens (17-20).
Lack of medication was not the reason: Of the 334 patients, 59% were taking metformin, 40% insulin, 38% thiazolidinediones, 36% sulfonylureas, and 16% non-sulfonylurea secretagogues (8% repaglinide and 8% nateglinide).
In addition to diet and exercise, oral treatment options have been broadened, with both insulin secretagogues and insulin sensitizers.
The current treatment for constipation relies on dietary fiber supplements, laxatives and intestinal fluid secretagogues.

Full browser ?